NCT05565638 2025-09-25
PROFAST
Dana-Farber Cancer Institute
Phase NA Completed
Clinical Trials
3 trialsNCT04617704 2021-09-22
BCMA and CD19 Targeted Fast Dual CART for Chromosomal Abnomalities High-risk BCMA+ Multiple Myeloma
Shanghai Changzheng Hospital
Phase EARLY_PHASE1 Unknown
NCT04236011 2021-06-15
BCMA and CD19 Targeted Fast Dual CAR-T for BCMA+ Refractory/Relapsed Multiple Myeloma
Shanghai Changzheng Hospital
Phase EARLY_PHASE1 Unknown